Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy
Crossref DOI link: https://doi.org/10.1007/s12282-017-0786-8
Published Online: 2017-06-05
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pan, Linlin
Duan, Junwu
Qiao, Weiqiang
Bi, Lirong
Wu, Di
Fan, Zhimin
Yang, Ming
Funding for this research was provided by:
Science and Technology Development Project of Jilin Province (20150312033ZG)
License valid from 2017-06-05